Prostatakarzinomdetektionsraten

Turk, Zmago; Hollberg, Helge; Dill, T.; I, Kaspers; Isbarn, Hendrik

doi:10.1007/s00120-014-3648-4

Cited by 3 publications

(1 citation statement)

References 9 publications

(15 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…1,2 In 2020, there were 1.41 million new cases of prostate cancer in the world, and 380 000 people died of prostate cancer, ranking fifth among male cancers in terms of mortality rate. 3 As the gold standard for prostate cancer detection, 4 a needle biopsy is currently primarily conducted with ultrasound, magnetic resonance imaging (MRI) and computed tomography (CT) guidance to effectively detect cancer cases. [5][6][7] Four main treatment methods exist for prostate cancer: radical resection, external radiation, highintensity focused ultrasound and brachytherapy.…”

Section: Introductionmentioning

confidence: 99%

A review of the research progress of interventional medical equipment and methods for prostate cancer

Wang

Zhang

Zuo

et al. 2021

Robotics Computer Surgery

View full text Add to dashboard Cite

Background: Prostate cancer is a common disease in men and has a relatively high mortality rate. However, the interventional medical equipment used for prostate biopsy and brachytherapy has always been a social concern.Methods: To understand interventional medical equipment for prostate cancer, the structure of manual, semi-automatic and automatic medical equipment were considered as the mainline, while the corresponding research on these structures were the auxiliary lines. The characteristics and corresponding research status have been discussed.Results: Interventional medical equipment for prostate cancer with different degrees of automation and its characteristics were determined, and the imaging principles and characteristics of computed tomography, transrectal ultrasound and magnetic resonance imaging have been briefly described. Conclusion:Certain feasible research suggestions have been proposed for future development from the perspective of structure, accuracy and safety. These include flexible and compact robot structures, high-precision image recognition and guidance, accurate dose planning and monitoring, real-time imaging monitoring without delay, high-precision needle insertion strategy, master-slave control, virtual reality and remote control.

show abstract

Section: Introductionmentioning

confidence: 99%

A review of the research progress of interventional medical equipment and methods for prostate cancer

Wang

Zhang

Zuo

et al. 2021

Robotics Computer Surgery

View full text Add to dashboard Cite

show abstract

A non-interventional, prospective, multicenter study for evaluation of the use of the herbal medicinal product Canephron® N in the pediatric outpatient population in Russia

et al. 2018

View full text Add to dashboard Cite

Background: A herbal medicinal product (HMP) with centaury, lovage, and rosemary as active ingredients (brand name: Canephron® N) has been widely used for treatment and prevention of urinary tract infections (UTIs) and other urinary system disorders. Non-clinical in vitro and in vivo data indicate its diuretic, spasmolytic, anti-inflammatory, antioxidative and analgesic effects. The purpose of this non-interventional, prospective, multicenter study was to collect data on the use of the HMP in the Russian pediatric outpatient population. Results: In total, 636 outpatients aged 1-17 years were enrolled. Of these, 634 received at least one dose of the HMP and were included in the safety set, which was used for analysis. 61 patients were 12-23 months, 227 were 2-5 years, 234 were 6-11 years and 112 were 12-17 years of age. The oral solution of the HMP was prescribed in 66.4%, and tablets (dragées) in 33.6% of the patients. For 48% of the patients the HMP was prescribed to treat an acute or chronic disease, 25% of the patients received it for prophylaxis, and 27% for both. More than half of the patients (53%) received the HMP as monotherapy. Main treatment indications were UTIs (34.1%) and pyelonephritis (30.0%). The proportion of UTIs was the highest within the youngest age group (51%), while the proportion of different cystitis forms increased in patients older than 2 years. Relevant proportions of different nephritis forms and urolithiasis were only observed in patients aged 12-17 years. Forms of cystitis were more frequent in female than in male patients (15% vs. 1%), while forms of nephritis, urolithiasis, and dysmetabolic nephropathy / crystalluria were more frequent in male patients. At the end of the observational period, 20% of the patients were reported as recovered from their disease, and 65% were reported to show improvements. For 91% of all patients with HMP monotherapy the investigators evaluated the effectiveness of the HMP as 'good' or 'very good'. Nearly all patients (99%) evaluated the tolerability as 'good'or 'very good'. Five adverse drug reactions were observed. Conclusions: The treatment of children aged 1-17 years with the HMP is safe and well tolerated. The study results support the use of the HMP for treatment and prophylaxis of urinary system diseases.

show abstract